Disappointing earnings sent the markets tumbling to a sharply lower open with the Dow plummeting 125 points to 14,631. Nasdaq plunged 50 points to 3213.
On the upside
A Seeking Alpha contributor expects Acura Pharmaceuticals (Nasdaq: ACUR) to benefit from the Food and Drug Administration's statement that abuse deterrent opioid analgesics were a priority.
OCZ Technology (Nasdaq: OCZ) updated investors on the progress of its financial restatements.
Alkermes (Nasdaq: ALKS) reported positive results from a Phase 2 trial of its major depressive disorder treatment ALKS 5461.
On the downside
Cirrus Logic (Nasdaq: CRUS) forecast first quarter revenue below analyst expectations.
First quarter earnings slipped for Textron (NYSE: TXT) and the company cut its 2013 outlook.
Shares of Magnum Hunter (NYSE: MHR) continued falling after the oil and gas company provided an operational update yesterday.
In the broad market, declining issues outpaced advancers by a margin of 7 to 2 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 index tumbled 19 points to 1554.
